Sierra Oncology, Inc Sierra (NASDAQ: SRRA) Confirms Acquisition Agreement with GlaxoSmithKline Sierra Oncology, Inc. (NASDAQ: SRRA) and GlaxoSmithKline plc (NYSE: GSK) confirmed that they both have inked an acquisition agreement. As per the agreement, GlaxoSmithKline will buy Sierra Oncology for $55
